-
Pfizer, BioNTech to Supply the EU with 100 mn additional COVID-19 vaccine doses
expresspharma
December 31, 2020
Total doses ordered reaches 300 million for 27 EU member states, all 300 million doses expected to be delivered in 2020 and 2021.
-
Pfizer, BioNTech to Supply U.S. With 100 Million Additional Doses of Covid-19 Vaccine
americanpharmaceuticalreview
December 24, 2020
Pfizer and BioNTech have announced a second agreement with the U.S. government to supply an additional 100 million doses of the companies’ COVID-19 Vaccine from production facilities in the U.S.
-
Pfizer, BioNTech win EU authorisation for COVID-19 vaccine Comirnaty
pharmatimes
December 23, 2020
The European Commission (EC) has granted Pfizer/BioNTech’s COVID-19 vaccine a conditional marketing authorisation (CMA), under the new name Comirnaty.
-
Pfizer, BioNTech Receive CHMP Positive Opinion for COVID-19 Vaccine
americanpharmaceuticalreview
December 23, 2020
Pfizer and BioNTech announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion to recommend the conditional marketing authorization (CMA) of the Pfizer-BioNTech COVID-19 vaccine ...
-
BioNTech-Pfizer vaccine heads to EU as effectiveness against new strain tested
expresspharma
December 23, 2020
The European Union is gearing up for a vaccination campaign of unprecedented scale following regulatory approval for the shot on Monday.
-
Pfizer and BioNTech get EU authorisation for COVID-19 Vaccine
expresspharma
December 22, 2020
Pfizer and BioNTech announced that the European Commission (EC) has granted a conditional marketing authorisation (CMA) to Pfizer and BioNTech for COMIRNATY (also known as BNT162b2), for active immunisation to prevent COVID-19 caused by SARS-CoV-2 ...
-
BioNTech and Fosun to supply 100 million Covid-19 vaccine doses to China
pharmaceutical-technology
December 18, 2020
German company BioNTech and Shanghai Fosun Pharmaceutical (Fosun Pharma) have entered into an agreement to supply initially 100 million doses of mRNA-based Covid-19 vaccine candidate, BNT162, to Mainland China next year.
-
Pfizer’s COVID-19 vaccine data accessed in EMA cyber-attack
europeanpharmaceuticalreview
December 15, 2020
Pfizer and BioNTech told that documents relating to their COVID-19 vaccine approval were accessed during a cyber-attack on the European Medicines Agency (EMA).
-
Safety and efficacy data from Phase III trial of BNT162b2 vaccine published
europeanpharmaceuticalreview
December 15, 2020
Pfizer and BioNTech’s data on BNT162b2, their COVID-19 vaccine, has been published in a new scientific paper, demonstrating its 95 percent efficacy rate.
-
US begins transportation of COVID-19 vaccine to distribution points around the country
expresspharma
December 15, 2020
Cargo planes and trucks with the first US shipments of coronavirus vaccine fanned out from FedEx and UPS hubs in Tennessee and Kentucky on Sunday en route to distribution points around the country, launching an immunisation project of unprecedented ...